| Not Yet Recruiting | Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function Esophageal Cancer, Advanced Solid Tumor | Phase 1 | 2026-10-30 |
| Not Yet Recruiting | Single-ascending Dose Study of HEC-151 Injection Healthy Adult Male | Phase 1 | 2026-03-11 |
| Not Yet Recruiting | A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effect Healthy Adult Subject | Phase 1 | 2026-03-04 |
| Not Yet Recruiting | Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF Idiopathic Pulmonary Fibrosis (IPF) | Phase 3 | 2025-10-09 |
| Completed | Clinical Study on the Mass Balance of Clifutinib Healthy Adult Male | Phase 1 | 2025-09-29 |
| Not Yet Recruiting | A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subje Healthy Subjects | Phase 1 | 2025-08-31 |
| Not Yet Recruiting | A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects Non - Alcoholic Steatohepatitis | Phase 1 | 2025-08-14 |
| Completed | ADME Study of [14C] Yiqibuvir in Healthy Male Subjects Healthy Male Subjects | Phase 1 | 2023-08-07 |
| Unknown | A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ry Diabetes | Phase 3 | 2023-05-01 |
| Recruiting | HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML Leukemia, Acute Myeloid (AML) | Phase 3 | 2023-03-03 |
| Recruiting | A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolera Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF) | Phase 2 | 2023-02-15 |
| Unknown | Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations Advanced NSCLC | Phase 2 | 2022-11-27 |
| Completed | ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects Healthy Male Subjects | Phase 1 | 2022-11-15 |
| Completed | Clifutinib Food Effect Study in Healthy Subjects Acute Myeloid Leukemia in Children | Phase 1 | 2022-11-08 |
| Completed | Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114 Healthy Subjects | Phase 1 | 2022-11-07 |
| Recruiting | A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagno Acute Myeloid Leukemia, Adult | Phase 1 / Phase 2 | 2022-10-31 |
| Recruiting | HEC169096 in Participants With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2022-10-21 |
| Completed | Study on the Body Mass Balance and Biotransformation of [14C]-HEC585 Healthy Volunteer | Phase 1 | 2022-07-26 |
| Completed | A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects Type 2 Diabetes | Phase 1 | 2022-05-31 |
| Unknown | A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Type 2 Diabetes | Phase 1 | 2022-05-05 |
| Unknown | A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subject Diabetes Mellitus, Type 2 | Phase 1 | 2022-04-19 |
| Completed | Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects Type 2 Diabetes Mellitus | Phase 1 | 2022-02-21 |
| Completed | ADME Study of [14C]- Rongliflozin in Healthy Male Subjects Healthy Adult Male Volunteers | Phase 1 | 2021-12-09 |
| Completed | A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Partici Healthy Volunteers | Phase 1 | 2021-11-24 |
| Unknown | A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing Gout | Phase 1 | 2021-11-22 |
| Completed | ADME Study of [14C]- Larotinib in Healthy Male Subjects Healthy Adult Male Volunteers | Phase 1 | 2021-11-20 |
| Completed | A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Al Non-Alcoholic Steatohepatitis | Phase 2 | 2021-11-15 |
| Completed | HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia Chronic Kidney Diseases, Renal Anemia | Phase 1 | 2021-11-04 |
| Unknown | The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Diso Depressive Disorder, Major | Phase 2 / Phase 3 | 2021-11-01 |
| Completed | Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Hepatitis B, Chronic | Phase 1 | 2021-10-11 |
| Completed | A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Inject Type 2 Diabetes | Phase 1 | 2021-10-08 |
| Completed | Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. Hemodialysis, Peritoneal Dialysis | Phase 1 | 2021-09-10 |
| Completed | Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Influenza | Phase 1 | 2021-08-24 |
| Unknown | Phase ll Study of HEC585 in Patients With IPF Idiopathic Pulmonary Fibrosis | Phase 2 | 2021-06-30 |
| Completed | To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers Idiopathic Pulmonary Fibrosis | Phase 1 | 2021-06-23 |
| Completed | Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatit Chronic HCV Infection | Phase 2 / Phase 3 | 2021-06-21 |
| Completed | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects Diabetic Nephropathy | Phase 1 | 2021-05-24 |
| Completed | Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD Renal Impairment | Phase 1 | 2021-04-15 |
| Unknown | A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refrac Relapsed or Refractory B-cell Hematologic Malignancies | Phase 1 | 2021-04-01 |
| Recruiting | Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer Esophageal Cancer | Phase 3 | 2021-01-21 |
| Completed | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Ad Parkinson Disease | Phase 1 | 2021-01-20 |
| Unknown | the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets Insomnia | Phase 1 | 2021-01-18 |
| Completed | GLS4/RTV and TAF Drug-drug Interaction Chronic Hepatitis B | Phase 1 | 2021-01-10 |
| Completed | To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Sev Hepatic Impairment | Phase 1 | 2020-10-19 |
| Terminated | Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Cha Hepatitis B, Chronic | Phase 1 / Phase 2 | 2020-10-09 |
| Completed | Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects Nonalcoholic Steatohepatitis (NASH) | Phase 1 | 2020-09-14 |
| Completed | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis | Phase 1 | 2020-08-10 |
| Completed | Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects Chronic Hepatitis C | Phase 1 | 2020-07-15 |
| Completed | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female S Idiopathic Pulmonary Fibrosis | Phase 1 | 2020-07-13 |
| Completed | The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects Chronic Hepatitis C | Phase 1 / Phase 2 | 2020-07-06 |
| Completed | A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects Type 2 Diabetes | Phase 1 | 2020-06-22 |
| Unknown | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy S Insomnia | Phase 1 | 2020-04-01 |
| Completed | the Safety, Tolerability, and Pharmacokinetics Study of HEC113995 Major Depressive Disorder | Phase 1 | 2020-03-30 |
| Completed | The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects Nonalcoholic Steatohepatitis (NASH) | Phase 1 | 2020-01-03 |
| Completed | The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects Chronic Hepatitis C | Phase 1 | 2019-12-18 |
| Terminated | Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer Pancreatic Cancer | Phase 1 | 2019-11-11 |
| Completed | The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subject Healthy | Phase 1 | 2019-07-04 |
| Completed | The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects Major Depressive Disorder | Phase 1 | 2019-07-04 |
| Completed | HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers Healthy | Phase 1 | 2019-05-14 |
| Completed | The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects Chronic Hepatitis C | Phase 1 | 2019-03-06 |
| Completed | Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Chronic HBV Infection | Phase 2 | 2019-02-28 |
| Completed | Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors Advanced Refractory Solid Tumors | Phase 1 | 2019-02-27 |
| Unknown | The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects Healthy | Phase 1 | 2018-11-21 |
| Completed | The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects Asthma | Phase 1 | 2018-10-25 |
| Completed | The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects Chronic Hepatitis c | Phase 1 | 2018-09-04 |
| Completed | A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects Chronic Hepatitis B | Phase 1 | 2018-06-26 |
| Terminated | A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastat Renal Cell Cancer Metastatic | Phase 1 / Phase 2 | 2018-06-25 |
| Completed | A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML) Acute Myeloid Leukemia | Phase 1 | 2018-05-18 |
| Completed | The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects Idiopathic Pulmonary Fibrosis | Phase 1 | 2018-04-26 |
| Completed | Phase 3 Study of Yimitasvir Phosphate Capsules Chronic HCV Infection | Phase 3 | 2018-04-17 |
| Completed | The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects Chronic Hepatitis c | Phase 1 | 2018-01-11 |
| Terminated | A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia (AML) | Phase 1 | 2017-11-13 |
| Completed | Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification Esophageal Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2017-08-18 |
| Completed | Phase 2 Study of Yimitasvir Phosphate Capsules Chronic HCV Infection | Phase 2 | 2017-07-31 |
| Completed | The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules Chronic Hepatitis B | Phase 2 | 2017-07-26 |
| Completed | The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects Idiopathic Pulmonary Fibrosis | Phase 1 | 2017-05-20 |
| Unknown | Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2016-11-01 |
| Completed | The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects Chronic Hepatitis c | Phase 1 | 2014-12-03 |
| Completed | First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2014-02-08 |